Is a complete ENVB research report available?

No complete published report is available for Enveric Biosciences, Inc. (ENVB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Enveric Biosciences, Inc. (ENVB)

NASDAQ: ENVB · USD

$1.29

-0.03 (-2.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first ENVB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	4.7M
Net income (ttm)	-11.6M
EPS (ttm)	-$17.2
Shares out	3.7M
Volume	107,445
Beta	1.14

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -11.6M
EPS (ttm): -$17.2
Market cap: 4.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All ENVB indicators

Market & fundamental data

Available fields

170

Groups with data

Currency

USD

Showing 170 of 170 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000890821
Company name	Enveric Biosciences, Inc.
Country	United States
Country code	US
Cusip	29405E505
Employees	6
Employees Change	-1%
Employees Change Percent	-14.29
Enterprise value	$-159,139
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US29405E5050
Last refreshed	2026-07-25
Market cap	$4.7M
Market cap category	Nano-Cap
Price	$1.29
Price currency	USD
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	2834
Symbol	ENVB
Website	https://www.enveric.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-243.81%
FCF yield	-168.58%
P/B ratio	0.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-11.6M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.9M
ROA	-96.72
Roa5y	-108
ROCE	-162.4
ROE	-183.1
Roe5y	-303.9
ROIC	-114.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-92.17%
Cagr3y	-86.5%
Cagr5y	-85.05%
EPS Growth Quarters	11
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$5.5M
Cash	$4.9M
Current Assets	$5.4M
Current Liabilities	$460,676
Debt	$0
Equity	$5.1M
Interest Coverage	-20,000.2
Liabilities	$460,676
Long Term Assets	$146,365
Long Term Liabilities	$0
Net Cash	$4.9M
Net Cash By Market Cap	$103
Net Cash Growth	14.31%
Net Debt Equity	$-0.97
Tangible Book Value	$5.1M
Tangible Book Value Per Share	$2.68
WACC	10.54

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.67
Net Working Capital	$5,654
Quick ratio	10.66
Working Capital	$4.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-814.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-92.15%
200-day SMA	3.61
3Y total return	-99.75%
50-day SMA	1.67
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.99%
All Time High	63,000
All Time High Change	-100%
All Time High Date	2021-03-10
All Time Low	1.25
All Time Low Change	3.2%
All Time Low Date	2026-07-23
ATR	0.13
Beta	1.14
Beta1y	0.39
Beta2y	0.69
Ch YTD	-64.46
High	1.31
High52	17.64
High52 Date	2025-08-27
High52ch	-92.69%
Low	1.25
Low52	1.25
Low52 Date	2026-07-24
Low52ch	3.2%
Ma50ch	-22.66%
Price vs 200-day SMA	-64.24%
RSI	36.91
RSI Monthly	11.37
RSI Weekly	34.56
Sharpe ratio	-0.72x
Sortino ratio	-1.26
Total Return	-814.4%
Tr YTD	-64.46
Tr1m	-4.44%
Tr1w	-3.73%
Tr3m	-67.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8.2M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,543,876%
Float Percent	96.25%
Shares Insiders	3.75%
Shares Institutions	3.55%
Shares Out	3,681,884
Shares Qo Q	128.96%
Shares Yo Y	814.4%
Short Float	0.44%
Short Ratio	0.07
Short Shares	0.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-8.7M
Average Volume	117,234.9x
Bv Per Share	2.68
Ch1m	-4.44
Ch1w	-3.73
Ch1y	-92.15
Ch3m	-67.91
Ch3y	-99.75
Ch5y	-99.99
Ch6m	-69.5
Change	-2.27%
Change From Open	-0.77
Close	1.32
Days Gap	-1.52
Depreciation Amortization	157,074
Dollar Volume	138,604.1
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-8.2M
EBITDA	$-8.1M
EPS	$-17.16
F Score	2
FCF	$-8M
FCF EV Yield	5,031.32x
FCF Per Share	$-2.17
Financing CF	8,633,801
Fiscal Year End	December
Founded	1,994
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2025-10-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-27
Ma150	2.56
Ma150ch	-49.63%
Ma20	1.37
Ma20ch	-5.98%
Net CF	614,334
Next Earnings Date	2026-08-13
Open	1.3
Optionable	No
Position In Range	66.67
Post Close	1.29
Postmarket Change Percent	-2.28
Postmarket Price	$1.26
Ppne	119,927
Price Date	2026-07-24
Ptbv Ratio	0.94
Relative Volume	0.92x
Share Based Comp	722,148
Tr6m	-69.5%
Us State	Massachusetts
Volume	107,445

Enveric Biosciences, Inc. (ENVB)

Coverage state: Market snapshot only — no published research

Generate the first ENVB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · ENVB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ENVB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ENVB

Frequently asked questions